STL Volume 17 Number 2

Update on Drugs and Drug News: February 2012
Update on drugs, approval dates, and comments. Adapalene 0.1% + benzoyl peroxide 2.5% gel (Epiduo®), Hyaluronic acid-based dermal filler (Belotero® Balance), Drospirenone 3 mg + ethinyl estradiol 0.02 mg (Vestura™) are covered.
Diagnostics and Devices Introduced in 2011
An overview and update of diagnostics and devices introduced in 2011: HPV RNA detection kit APTIMA® HPV Assay, HPV DNA detection kit cobas® HPV Test cobas® 4800 System, Microwave-based device (miraDry®) for hyperhydrosis and many more drugs and devices are covered.
Skin Treatments Introduced in 2011
An overview and update of skin treatments introduced in 2011: Adapalene 0.1% + benzoyl peroxide 2.5% gel (Tactuo™), 5-fluorouracil cream 0.5% + salicylic acid 10% (Actikerall®), Autologous cell therapy dermal filler laVív® (azficel-T) and more drugs are covered.
Laser Management of Acne Scarring
Acne scarring is often challenging to manage. This article discusses various laser treatments that are helpful in addressing abnormal color and texture in order to improve the appearance of an acne scar as well as review the appropriate use and side-effects of these treatments.
Ingenol Mebutate: An Introduction
The incidence of nonmelanoma skin cancer continues to increase. This article discusses ingenol mebutate, its history, mechanism of action, and recent trial evidence for this emerging therapy are discussed.